Step 1. Select the specific obese patient group, study follow-up time, or study design you are interested in.

Step 2. Find out how well metabolic bariatric surgery works, how well it is tolerated, and the level of evidence supporting these results...

Tumor Profile
MBS
Metabolic Bariatric Surgery
SG
Sleeve Gastrectomy
RYGB
Roux-en-Y Gastric Bypass
GB
Gastric Banding
Overall Cancer
OR = 0.72 (0.67, 0.78)
OR = 0.43 (0.28, 0.68)
OR = 0.46 (0.33, 0.63)
OR = 0.72 (0.45, 1.15)
Gastric Cancer (GC)
OR = 0.98 (0.51, 1.89)
—
OR = 0.86 (0.36, 2.05)
—
Pancreatic Cancer
RR = 0.46 (0.30, 0.72)
RR = 0.24 (0.12, 0.46)
RR = 0.52 (0.25, 1.10)
—
Colorectal Cancer (CRC)
OR = 0.76 (0.64, 0.89)
OR = 0.59 (0.37, 0.93)
OR = 0.47 (0.36, 0.61)
OR = 1.40 (0.28, 6.94)
Multiple Myeloma
RR = 0.52 (0.32, 0.84)
—
OR = 0.72 (0.49, 1.06)
—
Liver Cancer
OR = 0.45 (0.34, 0.59)
—
OR = 0.60 (0.49, 0.72)
—
Lung Cancer
OR = 0.38 (0.17, 0.84)
—
OR = 0.52 (0.42, 0.64)
—
Esophageal Cancer
OR = 0.80 (0.64, 1.00)
OR = 0.96 (0.38, 2.44)
OR = 0.65 (0.39, 1.09)
—
Gallbladder Cancer
OR = 0.80 (0.54, 1.21)
—
OR = 0.60 (0.33, 1.11)
—
Urinary Tract Cancers
OR = 0.77 (0.72, 0.83)
—
OR = 0.75 (0.58, 0.99)
—
Kidney Cancer
OR = 0.50 (0.32, 0.78)
———
Thyroid Cancer
OR = 0.84 (0.64, 1.10)
———
Melanoma
OR = 0.73 (0.34, 1.61)
———
Non-Hodgkin's Lymphoma (NHL)
OR = 0.49 (0.24, 1.01)
———
Skin Cancers
OR = 1.14 (0.81, 1.60)
———
Central Nervous System Cancers (CNS)
OR = 0.76 (0.31, 1.85)
———